Literature DB >> 2687005

Phase II multicentre study of the nitrosourea fotemustine in inoperable squamous cell lung carcinoma.

T Le Chevalier1, C Zabbe, S Gouva, M L Cerrina, E Quoix, A Riviere, P Berthaud, C Prache, J Berille.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2687005     DOI： 10.1016/0277-5379(89)90312-x

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  2 in total

1.  Phase II study of fotemustine in untreated inoperable non-small-cell lung cancer.

Authors:  R Rudd; R Allen; J Berille; S G Spiro; C Trask; R L Souhami
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer.

Authors:  J L Pujol; A Monnier; J Berille; M L Cerrina; J Y Douillard; A Rivière; A Grandgirard; S Gouva; J P Bizzari; T Le Chevalier
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.